Board of Directors

Ronald Cacciola is Chief Investment Officer of Zurich Alternative Asset Management, LLC (ZAAM), a wholly owned subsidiary of Zurich Financial Services Group. He has 26 years of investment experience and related finance experience. Prior to co-founding ZAAM, from 1995 to 2005, Mr. Cacciola served in various senior investment roles for Zurich in the United States and Switzerland. Previously, he managed fixed-income teams at Home Insurance Company, County NatWest, Security Pacific and Merrill Lynch.

Christopher French is a Senior Managing Director at Winterberry Group. Winterberry provides advisory services to companies in the marketing services & technology, interactive advertising and specialty media industries. Prior to joining Winterberry Group, Mr. French served as President and Chief Executive Officer of the Cadient Group, a leading strategic interactive marketing agency for life science companies. Previously, Mr. French spent eight years at Dendrite International, a provider of software, information and service solutions to the global life sciences industry. There he served in a number of capacities; including senior vice president of global solutions marketing and corporate development and general counsel.

As founder and Managing Partner of Edison Venture Fund, Martinson shapes overall investment strategies, mentors rising investment professionals and assists general partners in growing their practices. John also leads Edison’s investments in information technology companies serving the pharmaceutical industry and education. With 28 years of venture capital experience, John has guided 150 equity financings, served on the boards of 40 companies and has made multiple investments in application software serving the drug industry, CRM, education, HR, manufacturing and enterprise solutions. As a board member, he contributes expertise in strategy, marketing and business planning.

Greg Mistele is the Head of Alternative Investments for Honeywell Capital Management. He previously worked as Vice President of Mergers & Acquisitions for a Fortune 500 company, served as Principal of a technology and telecommunications investment bank, and as Associate Director of a corporate strategy firm. Greg holds an MBA from Duke University and a BA from the University of Virginia.

Matt Reichert is President, and CEO of Health Market Science. He joined the company in 2001 as the Vice President of Sales and Operations. Since then, Matt has managed the launch of several new products, aggressive revenue growth, and developed the infrastructure and team to support the company's rapid growth. Matt brings to the board 22 years of pharmaceutical and IT industry experience, serving in various leadership and executive functions for pharmaceutical-centric businesses, including Mediconsult, Dupont Pharmaceuticals, AstraMerck, and GE.

John M. Ryan is President of Devon Hill Ventures, an angel-investing firm focused on early-stage information technology companies. Over the past 17 years John has been an investor and/or an active director in nearly twenty IT companies. Current boards include: eResearchTechnology, Inc. (Nasdaq:NRWE), Neoware Systems, Inc. (Nasdaq:NWRE), IPR International, Inc., and Health Market Science, Inc. Previously, he was the founder of SunGard Data Systems, Inc. and served as its CEO and Chairman through its MBO and IPO until 1988.

Stephen Wray is President and CEO of Cadient Group, a leading independent healthcare-focused interactive communications company. He oversees worldwide business operations for the firm, including strategic and financial direction, corporate and product development, as well as investor and industry relations. With over 25 years of experience in healthcare communications, Steve was also Vice President of Marketing Communications for Wyeth and the Co-founder and Chairman Emeritus to the AWARE Foundation, a Philadelphia-based non-profit organization that provides health and wellness education.